Why TransMedics Stock Plunged in October

The organ transplant specialist posted disappointing results in its third-quarter report.Shares of TransMedics (TMDX -1.35%), a biotech company that specializes in organ transportation, were tumbling last month after it issued disappointing results in its third-quarter update.TransMedics shares had been soaring prior to the report as investors saw it as a disruptor in the industry, and it has put up impressive top-line growth.The third-quarter results called the valuation into question as the company's grow ...